Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
BTG INTERNATIONAL LIMITED et al v. TEVA PHARMACEUTICALS USA, INC.. et al
Case Number:
2:17-cv-06435
Court:
Nature of Suit:
Patent - Abbreviated New Drug Application(ANDA)
Judge:
Firms
Companies
Sectors & Industries:
-
October 31, 2018
Judge Pauses Invalidation Of Patent For Janssen's Zytiga
A New Jersey federal judge on Tuesday paused his Friday order that invalidated a patent covering Janssen Biotech Inc.'s blockbuster oncology medication Zytiga, allowing the company to appeal the opinion to the Federal Circuit.
-
October 29, 2018
NJ Judge Invalidates Patent For Janssen Cancer Drug Zytiga
A New Jersey federal judge has invalidated a patent covering Janssen Biotech Inc.'s blockbuster oncology medication Zytiga, but said a host of generic-drug makers would have infringed that patent with their oncoming drugs had it been valid.